cGxP.wire https://validator.w3.org/feed/docs/rss2.html Nona Biosciences Develops AI Model for Human Antibodies Sunshine Biopharma Advances PLpro Inhibitor Toward IND Curi Bio Advances FDA ISTAND Qualification for BoNT Assay SMSbiotech Advances COPD Program With FDA IND Clearance Aptitude Metrix COVID Test Receives FDA 510(k) Clearance A2 Biotherapeutics Advances A2B395 in Solid Tumors Gilead and PAHO Expand Lenacapavir HIV Prevention Access DifGen Pharmaceuticals Wins FDA Approval for Epinephrine Genentech Advances Lunsumio in Phase III Follicular Lymphoma Merz Therapeutics Gains EU Approval for XEOMIN in Pediatric Spasticity Boehringer Ingelheim Launches PED Essentials for Patient Evidence SNIPR Advances SNIPR001 Into Phase 2 for E. coli Prevention SetPoint Medical Expands RA Neuroimmune Therapy in Oregon IASO Bio IASO208 Receives FDA IND Clearance Eisai, Biogen LEQEMBI Pen Approved in Japan for Alzheimer’s Lundbeck Vyepti Receives Japan Approval for Migraine Prevention Cambium Bio Advances Elate Ocular Into Phase 3 Vera Therapeutics TRUTAKNA Shows Two-Year Kidney Benefit Galderma Advances Restylane Volyme in Chinese Temple Hollowing Novo Nordisk to Share New Cardiometabolic Data at EASD 2026! Chemify Raises £22M to Scale AI-Driven Chemistry Circle Pharma Raises $92.5M to Advance CID-165 Twist Bioscience Joins Lilly TuneLab for Antibody Discovery Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia Gilead Accelerates Global Access Planning for Once-Yearly Lenacapavir Mission Bio Launches Tapestri Triomics for Single-Cell Analysis AbCellera Presents Phase 2 Data for ABCL635 Longeveron Reports ELPIS II Results for Laromestrocel MAIA Biotechnology Doses First U.S. Patient in THIO-101 Kestrel Therapeutics Gains FDA Fast Track for KST-6051 Cogent Biosciences Gains FDA Acceptance for Bezuclastinibm ReEmerge Raises $37M to Advance Brain Injury Technology Vertex Partners With Lindsey Vonn to Highlight JOURNAVX Arrowhead Advances ARO-DIMER-PA in Mixed Hyperlipidemia Jubilant Therapeutics Reports JBI-802 MPN Clinical Data Skyhawk Therapeutics Reports 15-Month SKY-0515 Results HDT Bio Leads ARPA-H Program for Personalized RNA Thryv Therapeutics Advances THRV-1268 for Heart Failure Care Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery Mighty Therapeutics Develops POLG Disease Model for Research Ractigen Therapeutics Reports First-In-Human RNA Activation Data Lumicell Expands LumiSystem Use in Breast Cancer Surgery Now Applied Photonix Launches FDA-Cleared ViroZap Air Device Nitinotes Begins EASE Clinical Trial Procedures in Italy MitoRx to Present MTRX31 Obesity Data at EASD 2026 Mayo Clinic, Thermo Fisher Launch Precure for Early Signs AI Xylo Bio Advances XYL-1001 Phase 1 Trial in Major Depression Allergan Aesthetics Advances Skin Longevity Science Research Nuvation Bio Reports Durable IBTROZI Efficacy in ROS1+ NSCLC Viatris WAKIX Approved in Japan for Sleep Disorders